BackTaro Pharmaceutical Industries Overview

Taro Pharmaceutical Industries Receivables

Latest receivables for TARO: $180M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$177.46M
↓ 31.61% YoYΔ $-82.01M vs prior year quarter

Peer trimmed avg / median

Loading

Taro Pharmaceutical Industries Receivables History

Loading

Taro Pharmaceutical Industries vs. peers: Receivables Comparison

Loading

Taro Pharmaceutical Industries Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Taro Pharmaceutical Industries (TARO) FAQ

As of the most recent data (March 2024), TARO shows a receivables of $180M. That compares with $260M in the prior-year period — down 31.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TARO's receivables is now $180M (was $260M) — a 31.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Taro Pharmaceutical Industries is outperforming or lagging.

Tracking TARO's receivables over time shows whether Taro Pharmaceutical Industries is scaling, shrinking, or reshaping that part of the business. The current reading is $180M That compares with $260M in the prior-year period — down 31.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Taro Pharmaceutical Industries's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $180M) with ownership activity and broader fundamentals.

Taro Pharmaceutical Industries's receivables is $180M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.